FDA.reportPublic FDA data

alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet

RxCUI
1368410
RxNorm name
alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Display name
alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Full name
alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alogliptin and PioglitazoneALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDEPadagis Israel Pharmaceuticals Ltd642b1e90-701e-42f2-bac6-a4918738e2c92025-07-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1368410
OSENIALOGLIPTIN AND PIOGLITAZONETakeda Pharmaceuticals America, Inc.4c619ed9-fe3e-4158-9938-80c6c3493d552025-02-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1368410

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4c619ed9-fe3e-4158-9938-80c6c3493d55alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral TabletSY23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
4c619ed9-fe3e-4158-9938-80c6c3493d55alogliptin 12.5 MG / pioglitazone 30 MG Oral TabletPSN23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
4c619ed9-fe3e-4158-9938-80c6c3493d55alogliptin 12.5 MG / pioglitazone 30 MG Oral TabletSCD23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
642b1e90-701e-42f2-bac6-a4918738e2c9alogliptin 12.5 MG / pioglitazone 30 MG Oral TabletPSN11These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 201320250728
642b1e90-701e-42f2-bac6-a4918738e2c9alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral TabletSY11These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 201320250728
642b1e90-701e-42f2-bac6-a4918738e2c9alogliptin 12.5 MG / pioglitazone 30 MG Oral TabletSCD11These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 201320250728